Nodes, paranodes and neuropathies Abstract Purpose of reviewThis review summarises recent evidence supporting the involvement of the specialized nodal and peri-nodal domains of myelinated axons in the pathology of acquired, inflammatory, peripheral neuropathies.
Recent findingsThe identification of new target antigens in the inflammatory neuropathies heralds a revolution in diagnosis, and has already begun to inform increasingly targeted and individualised therapies. Rapid progress in our basic understanding of the highly specialised nodal regions of peripheral nerves serves to strengthen the links between their unique microstructural identities, functions and pathologies. In this context, the detection of auto-antibodies directed against nodal and peri-nodal targets is likely to be of increasing clinical importance. Anti-ganglioside antibodies have long been used in clinical practice as diagnostic serum biomarkers, and associate with specific clinical variants but not to the common forms of either acute or chronic demyelinating autoimmune neuropathy. It is now apparent that antibodies directed against several region-specific cell adhesion molecules (CAMs), including neurofascin (NF), contactin (CNTN) and contactin-associated protein (Caspr), can be linked to phenotypically distinct peripheral neuropathies. Importantly, the immunological characteristics of these antibodies facilitate the prediction of treatment responsiveness.
SummaryThe search for the causes and mechanisms of inflammatory neuropathies has recently taken an exciting, new direction. The nodes of Ranvier, as well as the flanking paranodal and juxtaparanodal regions, have emerged as critical targets of the immuno-pathological processes underlying a sub-set of these conditions. These autoantibodies are diagnostically useful, especially when they predict the response to specific treatments. Along with recently developed humanised neuropathy models, this provides both the impetus and means to identify further serological markers of these immune-driven, potentially reversible conditions. The increasing ability to identify distinct pathological subtypes of these disorders is likely to foster increasingly targeted and personalized therapeutic approaches.
KeywordsNode, paranode, juxtaparanode, inflammatory neuropathy Introduction Acquired peripheral neuropathies have a wide range of causes, including some that can result in devastating neurological deficits, including paralysis, sensory loss, autonomic disturbances, and respiratory failure. GuillainBarré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) account for the majority of immune-mediated neuropathies. Within these broad groups, diverse subtypes are increasingly recognised. Because some of these have atypical features and respond poorly to standard therapies, their detection is of clear clinical importance.Highly specialized regions of the peripheral nerve, in particular the node and paranode, are currently in the spotlight, as their dysfunction following antibody-mediate...